Renova Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.52 Cr
as on 07-07-2024
- Paid Up Capital ₹ 2.52 Cr
as on 07-07-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.40 Cr
as on 07-07-2024
- Satisfied Charges ₹ 3.00 M
as on 07-07-2024
- Revenue 25.23%
(FY 2022)
- Profit 313.18%
(FY 2022)
- Ebitda 1.57%
(FY 2022)
- Net Worth 21.57%
(FY 2022)
- Total Assets 0.15%
(FY 2022)
About Renova Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.52 Cr and a paid-up capital of Rs 2.52 Cr.
The company currently has active open charges totaling ₹14.40 Cr. The company has closed loans amounting to ₹3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ankit Sheth, Milanbhai Sheth, and Darshit Sheth serve as directors at the Company.
- CIN/LLPIN
U24233GJ2010PTC063421
- Company No.
063421
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Renova Lifesciences Private Limited offer?
Renova Lifesciences Private Limited offers a wide range of products and services, including Eye Drops, Hydroxypropyl Methylcellulose Ophthalmic Solution, Eye Care Medicines, Nepafenac Ophthalmic Eye Drop, Common Disease Medicines, Carmellose Sodium Eye Drops, Ear Drops, Ointment, Eye Ointments.
Who are the key members and board of directors at Renova Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Darshit Sheth  | Director | 29-Dec-2010 | Current |
| Ankit Sheth | Director | 29-Dec-2010 | Current |
| Milanbhai Sheth | Director | 29-Dec-2010 | Current |
Financial Performance and Corporate Structure Insights of Renova Lifesciences.
Renova Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.23% increase. The company also saw a substantial improvement in profitability, with a 313.18% increase in profit. The company's net worth Soared by an impressive increase of 21.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Renova Lifesciences?
In 2021, Renova Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Megaren Lifesciences Private LimitedActive 11 months 15 daysAnkit Sheth and Darshit Sheth are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 14 Mar 2024 | ₹3.00 Cr | Open |
Sidbi Creation Date: 02 Nov 2017 | ₹11.40 Cr | Open |
Axis Bank Limited Creation Date: 04 Jun 2015 | ₹3.00 M | Satisfied |
How Many Employees Work at Renova Lifesciences?
Renova Lifesciences has a workforce of 39 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renova Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renova Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
